Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]

NCT00615550 is registered in ClinicalTrials.gov with Juniper Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00615550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00615550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]
Lead sponsor
Juniper Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
November 30, 2010
Enrollment
465 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

preterm delivery, short cervix, short uterine cervical length